Shenzhen Salubris Pharmaceuticals Co., Ltd.

This phase 2 trial tests whether an experimental oral drug, SAL0137, can safely lower high levels of lipoprotein(a) — a genetic risk factor for heart attacks and strokes that currently has no approved medication. About 120 adults with elevated Lp(a) and high cardiovascular risk w…

This early-stage trial is testing an experimental drug called SAL0167 in healthy adults to see if it is safe and how the body processes it. The goal is to gather initial data that could support future studies for treating high cholesterol. Participants will receive either the dru…

This Phase 2 trial tests whether the drug SAL0140 can reduce protein in the urine, a sign of kidney damage, in 249 adults with chronic kidney disease. Participants will receive either SAL0140 or a placebo for 16 weeks. The goal is to see if the drug can help control the disease a…

This phase 2 trial tests a new drug called SAL0140 in 50 adults with primary aldosteronism, a condition where the adrenal glands make too much aldosterone, causing high blood pressure. Participants will receive either SAL0140 or a placebo for 12 weeks to see if it safely lowers b…

This early-stage study tests whether a new single pill containing three blood pressure medicines works the same as taking two separate pills. The trial involves 60 healthy adults who will take both versions at different times to compare how their bodies absorb the drugs. The goal…